LYEL Lyell: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik lyell.com (LYEL)

Lyell Immunopharma focuses on reprogramming T-cells to combat solid tumors. The specifics of the R&D sector render the company independent of economic cycles. The price-to-sales multiple trend clearly captures the market valuation of the business, where 20104000.00 describes the current status of the metric. Leadership in creating exhaustion-resistant biomedical platforms provides the firm with powerful scientific potential.

Nilai perusahaan marang pendapatan: Lyell (LYEL) kanggo 23.11.2025 - 20.11.2026

lyell.com - rincian analitis lan metrik utama (LYEL)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Lyell Immunopharma LYEL
Sampel barang Lyell Immunopharma

Lyell Immunopharma's in-house manufacturing capabilities reduce operating expenses, which directly impacts revenue generation efficiency. The EV/Sales metric measures the total value of the business, including debt and cash, per unit of sales. By analyzing the EV/Sales multiple trajectory, an investor can see the market valuation of the asset stripped of leverage influence. The price action of the curve confirms the objectivity of the capitalization relative to actual cash flows, allowing for an assessment of the company's resilience to market volatility.

Analisis pesaing Lyell Immunopharma

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP